default author photo

Andrea Kroeker

University of Saskatchewan - Vaccine and Infectious Disease Organization

Saskatoon, Saskatchewan

Canada

SCHOLARLY PAPERS

2

DOWNLOADS

81

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Efficacy of a Stable Broadly Protective Subunit Vaccine Platform Against Sars-Cov-2 Variants of Concern

Number of pages: 43 Posted: 18 Apr 2024
University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, Vaccine Formulation Institute (VFI), University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, Vaccine Formulation Institute (VFI), Vaccine Formulation Institute (VFI), University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, Vaccine Formulation Institute (VFI), University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization and University of Saskatchewan - Vaccine and Infectious Disease Organization
Downloads 55 (1,010,164)

Abstract:

Loading...

SARS-CoV-2, subunit vaccine, broad protection, vaccine platform, emerging coronaviruses, Syrian hamsters

2.

Immunogenicity of Convalescent and Vaccinated Sera Against Clinical Isolates of Ancestral SARS-CoV-2, Beta, Delta, and Omicron Variants

Number of pages: 21 Posted: 10 Feb 2022
University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, Laboratory of Shenzhen Children’s Hospital, University of Toronto - Sunnybrook Research Institute, Dalhousie University, University of Toronto - Sunnybrook Research Institute, University of Saskatchewan, Students, University of Saskatchewan, Students, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Toronto - Department of Medicine, Mount Sinai Health System, Mount Sinai Health System, Mount Sinai Health System, University of Toronto - University Health Network, University of Toronto - Mount Sinai Hospital, Toronto, Mount Sinai Health System, University of Toronto - Department of Laboratory Medicine and Pathobiology, Sinai Health System TorontoUniversity of Toronto - Centre for Global Health Research, University of Toronto, University of Toronto - Sunnybrook Research Institute and University of Saskatchewan - Vaccine and Infectious Disease Organization
Downloads 26 (1,372,601)

Abstract:

Loading...

SARS-CoV-2, neutralization, variants of concern, omicron, vaccine, neutralizing antibodies